- Home
- FMTO vs KTTA Comparison
FMTO vs KTTA Comparison
Compare FMTO & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMTO
- KTTA
- Stock Information
- Founded
- FMTO 2000
- KTTA 2020
- Country
- FMTO Israel
- KTTA United States
- Employees
- FMTO N/A
- KTTA N/A
- Industry
- FMTO
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- FMTO
- KTTA Health Care
- Exchange
- FMTO NYSE
- KTTA Nasdaq
- Market Cap
- FMTO 2.3M
- KTTA 2.6M
- IPO Year
- FMTO N/A
- KTTA 2021
- Fundamental
- Price
- FMTO $3.52
- KTTA $1.30
- Analyst Decision
- FMTO
- KTTA
- Analyst Count
- FMTO 0
- KTTA 0
- Target Price
- FMTO N/A
- KTTA N/A
- AVG Volume (30 Days)
- FMTO 19.3K
- KTTA 3.3M
- Earning Date
- FMTO 03-31-2025
- KTTA 03-28-2025
- Dividend Yield
- FMTO N/A
- KTTA N/A
- EPS Growth
- FMTO N/A
- KTTA N/A
- EPS
- FMTO N/A
- KTTA N/A
- Revenue
- FMTO $754,768.00
- KTTA N/A
- Revenue This Year
- FMTO N/A
- KTTA N/A
- Revenue Next Year
- FMTO N/A
- KTTA N/A
- P/E Ratio
- FMTO N/A
- KTTA N/A
- Revenue Growth
- FMTO N/A
- KTTA N/A
- 52 Week Low
- FMTO $3.12
- KTTA $1.25
- 52 Week High
- FMTO $694.45
- KTTA $9.25
- Technical
- Relative Strength Index (RSI)
- FMTO N/A
- KTTA 30.34
- Support Level
- FMTO N/A
- KTTA $1.32
- Resistance Level
- FMTO N/A
- KTTA $1.38
- Average True Range (ATR)
- FMTO 0.00
- KTTA 0.26
- MACD
- FMTO 0.00
- KTTA -0.05
- Stochastic Oscillator
- FMTO 0.00
- KTTA 1.92
About FMTO FEMTO TECHNOLOGIES INC
Femto Technologies Inc is an integrated software company. It owns and markets Benefit CRM, a proprietary customer relationship management CRM software product enabling small and medium sized businesses to optimize their day to day business activities such as sales management, personnel management, marketing, call center activities, and asset management.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.